65 related articles for article (PubMed ID: 20819974)
21. Position paper/statement by members of the Ponte di Legno Group on the right of children to have full access to essential treatment for acute lymphoblastic leukemia.
Ponte di Legno Group
Haematologica; 2004 Sep; 89(9):1034-5. PubMed ID: 15377461
[No Abstract] [Full Text] [Related]
22. Acute lymphoblastic leukemia and Down syndrome: presenting features and treatment outcome in the experience of the Italian Association of Pediatric Hematology and Oncology (AIEOP).
Arico M; Ziino O; Valsecchi MG; Cazzaniga G; Baronci C; Messina C; Pession A; Santoro N; Basso G; Conter V;
Cancer; 2008 Aug; 113(3):515-21. PubMed ID: 18521927
[TBL] [Abstract][Full Text] [Related]
23. Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.
Huguet F; Leguay T; Raffoux E; Thomas X; Beldjord K; Delabesse E; Chevallier P; Buzyn A; Delannoy A; Chalandon Y; Vernant JP; Lafage-Pochitaloff M; Chassevent A; Lhéritier V; Macintyre E; Béné MC; Ifrah N; Dombret H
J Clin Oncol; 2009 Feb; 27(6):911-8. PubMed ID: 19124805
[TBL] [Abstract][Full Text] [Related]
24. Clinical trials referral resource. Clinical trials for children with acute leukemia.
Smith MA; Phillips PH; Cheson BD
Oncology (Williston Park); 1996 Nov; 10(11):1662, 1665-6. PubMed ID: 8953587
[No Abstract] [Full Text] [Related]
25. Toward a total cure for acute lymphoblastic leukemia.
Pui CH
J Clin Oncol; 2009 Nov; 27(31):5121-3. PubMed ID: 19805663
[No Abstract] [Full Text] [Related]
26. Risk-adapted treatment of pediatric acute lymphoblastic leukemia.
Jeha S; Pui CH
Hematol Oncol Clin North Am; 2009 Oct; 23(5):973-90, v. PubMed ID: 19825448
[TBL] [Abstract][Full Text] [Related]
27. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
[TBL] [Abstract][Full Text] [Related]
28. Environment and malignancies of the lymphatic system.
Ramot B; Ben-Bassat I
Princess Takamatsu Symp; 1987; 18():87-94. PubMed ID: 3333500
[TBL] [Abstract][Full Text] [Related]
29. Influence of socioeconomic status on childhood acute lymphoblastic leukemia treatment in Indonesia.
Mostert S; Sitaresmi MN; Gundy CM; Sutaryo ; Veerman AJ
Pediatrics; 2006 Dec; 118(6):e1600-6. PubMed ID: 17074838
[TBL] [Abstract][Full Text] [Related]
30. [Clinical study on mitoxantrone contained regimen for treatment of newly diagnosed childhood acute lymphoblastic leukemia].
Wang WQ; Liu XY; Liu LQ
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):602-3. PubMed ID: 16137060
[No Abstract] [Full Text] [Related]
31. Transplantations in adult acute lymphoblastic leukemia--grounds for optimism?
Goldstone AH
Clin Lymphoma Myeloma; 2009; 9 Suppl 3():S211-3. PubMed ID: 19778843
[TBL] [Abstract][Full Text] [Related]
32. Treatment of acute lymphoblastic leukemia in children: the Italian (AIEOP) experience.
Paolucci G; Masera G; Vecchi V; Zanesco L; Madon E; Mandelli F; Massimo L; Tognoni G; Zurlo MG; Pession A
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():95-7. PubMed ID: 2653527
[No Abstract] [Full Text] [Related]
33. Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.
Attarbaschi A; Mann G; Panzer-Grümayer R; Röttgers S; Steiner M; König M; Csinady E; Dworzak MN; Seidel M; Janousek D; Möricke A; Reichelt C; Harbott J; Schrappe M; Gadner H; Haas OA
J Clin Oncol; 2008 Jun; 26(18):3046-50. PubMed ID: 18565891
[TBL] [Abstract][Full Text] [Related]
34. High-risk childhood acute lymphoblastic leukemia in China: factors influencing the treatment and outcome.
Luo XQ; Ke ZY; Huang LB; Guan XQ; Zhang YC; Zhang XL
Pediatr Blood Cancer; 2009 Feb; 52(2):191-5. PubMed ID: 18989886
[TBL] [Abstract][Full Text] [Related]
35. Components of cure: treatment of acute lymphoblastic leukemia in Indonesia and other low-income countries.
Howard SC; Pui CH; Ribeiro RC
Pediatr Blood Cancer; 2008 Dec; 51(6):719-21. PubMed ID: 18816634
[No Abstract] [Full Text] [Related]
36. Cancer care and clinical research for children in less developed countries: problems and promise.
Simone JV
J Pediatr Hematol Oncol; 2000; 22(6):490-1. PubMed ID: 11132213
[No Abstract] [Full Text] [Related]
37. Outcome of acute lymphoblastic leukemia in India: the challenges ahead.
Kulkarni KP; Marwaha RK
J Pediatr Hematol Oncol; 2013 May; 35(4):334. PubMed ID: 23042007
[No Abstract] [Full Text] [Related]
38. Pediatric oncology in developing countries: a cooperative program in Nicaragua.
Masera G; Baez Lacayo F; Malta Corea A; Ocampo Hernandez E; Pacheco Espinoza C; Silva Espinoza F; Conter V; Biondi A; Lietti G; Sessa C
Ann Oncol; 1993 Jan; 4(1):37-40. PubMed ID: 8435360
[No Abstract] [Full Text] [Related]
39. Why don't cancer patients get entered into clinical trials? Experience of the Sheffield Lymphoma Group's collaboration in British National Lymphoma Investigation studies.
Hancock BW; Aitken M; Radstone C; Hudson GV
BMJ; 1997 Jan; 314(7073):36-7. PubMed ID: 9001479
[No Abstract] [Full Text] [Related]
40. Optimizing Pediatric Leukemia Care in Countries With Limited Resources.
Ribeiro RC; Conter V
J Clin Oncol; 2023 Jul; 41(19):3482-3485. PubMed ID: 37141548
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
